Table 2 NT-proBNP levels in patient subgroups by BMI categories

Age group

 < 50

4528

(2036–5416)

2837

(2837–2837)

3310

(470–5402)

0.779^c

 50–75

4645

(2021–9794)

3797

(1610–8603)

2570

(1099–5264)

0.055^c

 > 75

7340

(2534–17018)

1867

(833–4596)

3177

(1414–5139)

0.002^c

 p value

0.138^c

0.195^c

0.847^c

Gender

 Male

4528

(1530–11720)

1869

(1104–3797)

3202

(1707–5122)

0.018^c

 Female

5604

(2712–16785)

5850

(2363–9308)

2805

(1099–5237)

0.009^c

 p value

0.068^d

0.0017^d

0.912^d

Diabetes

 Yes

5338

(2419–15086)

3071

(1540–6801)

3139

(1262–5264)

0.0005^c

 No

4082

(1796–9239)

3589

(1324–12934)

4240

(1726–5122)

0.56^c

 p value

0.318^d

0.678^d

0.940^d

Hypertension

 Yes

4812

(1608–13134)

3693

(1867–10282)

2805

(914–5122)

0.04^c

 No

5352

(2455–15276)

2623

(1324–5850)

3189

(1707–5237)

0.002^c

 p value

0.478^d

0.226^d

0.497^d

LVEF (%)

 ≤ 40%

5703

(2712–15727)

4270

(1869–9308)

3591

(2164–7127)

0.039^c

 > 40%

3427

(1640–10757)

1867

(636–3776)

1951

(819–4240)

0.002^c

 p value

0.029^d

0.004^d

0.003^d

NYHA class

 II

3220

(1510–5793)

2218

(1324–5927)

1967

(578–3232)

0.039^c

 III–IV

8212

(2851–16785)

3932

(1610–8214)

4240

(1726–7143)

0.006^c

 p value

0.002^d

0.156^d

0.001^d